Youssef Errami

2.4k total citations · 1 hit paper
37 papers, 1.8k citations indexed

About

Youssef Errami is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Youssef Errami has authored 37 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 18 papers in Molecular Biology and 11 papers in Immunology. Recurrent topics in Youssef Errami's work include PARP inhibition in cancer therapy (10 papers), CRISPR and Genetic Engineering (8 papers) and CAR-T cell therapy research (8 papers). Youssef Errami is often cited by papers focused on PARP inhibition in cancer therapy (10 papers), CRISPR and Genetic Engineering (8 papers) and CAR-T cell therapy research (8 papers). Youssef Errami collaborates with scholars based in United States, Egypt and Saudi Arabia. Youssef Errami's co-authors include Sidi Chen, Guangchuan Wang, Amarjit S. Naura, Mourad Zerfaoui, Lupeng Ye, Xiaoyun Dai, Matthew B. Dong, Ryan D. Chow, A. Hamid Boulares and Jonathan J. Park and has published in prestigious journals such as Cell, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Youssef Errami

37 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy

2022 143 citations Lupeng Ye, Jonathan J. Park et al. Cell Metabolism profile →

Peers

Countries citing papers authored by Youssef Errami

Since Specialization

Citations

This map shows the geographic impact of Youssef Errami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youssef Errami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youssef Errami more than expected).

Fields of papers citing papers by Youssef Errami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youssef Errami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youssef Errami. The network helps show where Youssef Errami may publish in the future.

Co-authorship network of co-authors of Youssef Errami

This figure shows the co-authorship network connecting the top 25 collaborators of Youssef Errami. A scholar is included among the top collaborators of Youssef Errami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youssef Errami. Youssef Errami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical outcomes and tumor microenvironment response to radiofrequency ablation therapy: a systematic review and meta-analysis 2024 ·Gland Surgery ·Lauren Mueller, Peter P. Issa, Mohammad H. Hussein, Rami M. Elshazli, (unknown), Youssef Errami, Mohamed Shama, Manal S. Fawzy, Emad Kandil, Eman A. Toraih	5
2	Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function 2023 ·Cancer Immunology Research ·Paul Renauer, Jonathan J. Park, Meizhu Bai, (unknown), Won‐Ho Lee, (unknown), (unknown), Xiaoyun Dai, Guangchuan Wang, Youssef Errami, Terence Wu, Paul Clark, Lupeng Ye, Quanjun Yang, Sidi Chen	19
3	A Predictive Model of Adaptive Resistance to BRAF/MEK Inhibitors in Melanoma 2023 ·International Journal of Molecular Sciences ·Emmanuelle Ruiz, (unknown), Youssef Errami, Zakaria Y. Abd Elmageed, Jennifer S. Fang, Guangdi Wang, (unknown), (unknown), Emad Kandil, Mourad Zerfaoui	3
4	A miRNA-Based Prognostic Model to Trace Thyroid Cancer Recurrence 2022 ·Cancers ·Eman A. Toraih, Manal S. Fawzy, Bo Ning, Mourad Zerfaoui, Youssef Errami, Emmanuelle Ruiz, Mohammad H. Hussein, (unknown), Melyssa R. Bratton, Giovane G. Tortelote, Sylvia Hilliard, Naris Nilubol, Jonathon O. Russell, Mohamed Shama, Samir S. El‐Dahr, Krzysztof Moroz, Tony Hu, Emad Kandil	9
5	A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy breakdown → 2022 ·Cell Metabolism ·Lupeng Ye, Jonathan J. Park, Lei Peng, Quanjun Yang, Ryan D. Chow, Matthew B. Dong, Stanley Z. Lam, Jianjian Guo, Erting Tang, Yueqi Zhang, Guangchuan Wang, Xiaoyun Dai, Yaying Du, (unknown), (unknown), Youssef Errami, Paul Clark, Alexey Bersenev, Ruth R. Montgomery, Sidi Chen	143
6	Cell-Matrix Elastocapillary Interactions Drive Pressure-Based Wetting of Cell Aggregates 2022 ·Physical Review X ·Muhammad Sulaiman Yousafzai, (unknown), (unknown), Michael F. Staddon, Youssef Errami, (unknown), Shiladitya Banerjee, Michael P. Murrell	16
7	Targeting PARP-1 with metronomic therapy modulates MDSC suppressive function and enhances anti-PD-1 immunotherapy in colon cancer 2021 ·Journal for ImmunoTherapy of Cancer ·Mohamed A. Ghonim, Salomè V. Ibba, (unknown), Youssef Errami, (unknown), Matthew J. Dean, Ali H. El‐Bahrawy, Dorota Wyczechowska, (unknown), Luis Del Valle, Amir A. Al-Khami, Augusto C. Ochoa, A. Hamid Boulares	69
8	CRISPR-GEMM Pooled Mutagenic Screening Identifies KMT2D as a Major Modulator of Immune Checkpoint Blockade 2020 ·Cancer Discovery ·Guangchuan Wang, Ryan D. Chow, Lvyun Zhu, Zhigang Bai, Lupeng Ye, Feifei Zhang, Paul Renauer, Matthew B. Dong, Xiaoyun Dai, Xiaoya Zhang, Yaying Du, (unknown), Leilei Niu, Zhiyuan Chu, (unknown), Cun Liao, Paul Clark, Youssef Errami, Sidi Chen	87
9	In vivo CRISPR screening in CD8 T cells with AAV–Sleeping Beauty hybrid vectors identifies membrane targets for improving immunotherapy for glioblastoma 2019 ·Nature Biotechnology ·Lupeng Ye, Jonathan J. Park, Matthew B. Dong, Quanjun Yang, Ryan D. Chow, Lei Peng, Yaying Du, Jianjian Guo, Xiaoyun Dai, Guangchuan Wang, Youssef Errami, Sidi Chen	148
10	Multiplexed activation of endogenous genes by CRISPRa elicits potent antitumor immunity 2019 ·Nature Immunology ·Guangchuan Wang, Ryan D. Chow, Zhigang Bai, Lvyun Zhu, Youssef Errami, Xiaoyun Dai, Matthew B. Dong, Lupeng Ye, Xiaoya Zhang, Paul Renauer, Jonathan J. Park, Li Shen, (unknown), Charles S. Fuchs, Sidi Chen	88
11	One-step generation of modular CAR-T cells with AAV–Cpf1 2019 ·Nature Methods ·Xiaoyun Dai, Jonathan J. Park, Yaying Du, (unknown), Guangchuan Wang, Youssef Errami, Sidi Chen	107
12	In vivo profiling of metastatic double knockouts through CRISPR–Cpf1 screens 2019 ·Nature Methods ·Ryan D. Chow, Guangchuan Wang, Lupeng Ye, (unknown), (unknown), Li Shen, Matthew B. Dong, Youssef Errami, Sidi Chen	42
13	Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells 2019 ·Cell ·Matthew B. Dong, Guangchuan Wang, Ryan D. Chow, Lupeng Ye, Lvyun Zhu, Xiaoyun Dai, Jonathan J. Park, (unknown), Youssef Errami, Christopher D. Guzman, Xiaoyu Zhou, Krista Y. Chen, Paul Renauer, Yaying Du, Johanna Shen, Stanley Z. Lam, (unknown), Donald R. Lannin, Roy S. Herbst, Sidi Chen	213
14	Convergent Identification and Interrogation of Tumor-Intrinsic Factors that Modulate Cancer Immunity In Vivo 2019 ·Cell Systems ·(unknown), Paul Renauer, Guangchuan Wang, Ryan D. Chow, Jonathan J. Park, (unknown), Kerou Zhang, Matthew B. Dong, Brandon M. Gassaway, Lupeng Ye, Youssef Errami, Li Shen, Alan L. Chang, Dhanpat Jain, Roy S. Herbst, Marcus Bosenberg, Jesse Rinehart, Rong Fan, Sidi Chen	12
15	AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma 2017 ·Nature Neuroscience ·Ryan D. Chow, Christopher D. Guzman, Guangchuan Wang, Florian Schmidt, Mark W. Youngblood, Lupeng Ye, Youssef Errami, Matthew B. Dong, Michael A. Q. Martinez, Sensen Zhang, Paul Renauer, Kaya Bilgüvar, Murat Günel, Phillip A. Sharp, Feng Zhang, Randall J. Platt, Sidi Chen	175
16	ICAD Deficiency in Human Colon Cancer and Predisposition to Colon Tumorigenesis: Linkage to Apoptosis Resistance and Genomic Instability 2013 ·PLoS ONE ·Youssef Errami, Hassan Brim, (unknown), Mustapha Oumouna, Amarjit S. Naura, Hogyoung Kim, Jihang Ju, (unknown), (unknown), Hassan Ashktorab, Kenneth B. Fallon, Ming Xu, Jianhua Zhang, Luis Del Valle, A. Hamid Boulares	14
17	Apoptotic DNA Fragmentation May Be a Cooperative Activity between Caspase-activated Deoxyribonuclease and the Poly(ADP-ribose) Polymerase-regulated DNAS1L3, an Endoplasmic Reticulum-localized Endonuclease That Translocates to the Nucleus during Apoptosis 2012 ·Journal of Biological Chemistry ·Youssef Errami, Amarjit S. Naura, Hogyoung Kim, Jihang Ju, Yasuhiro Suzuki, Ali H. El‐Bahrawy, Mohamed A. Ghonim, Ramadan A.M. Hemeida, Moselhy S. Mansy, Jianhua Zhang, Ming Xu, Mark E. Smulson, Hassan Brim, A. Hamid Boulares	68
18	PARP-1 deficiency blocks IL-5 expression through calpain-dependent degradation of STAT-6 in a murine asthma model 2011 ·European Respiratory Journal ·Amarjit S. Naura, Rahul Datta, Mourad Zerfaoui, Youssef Errami, Mustapha Oumouna, Hogyoung Kim, Jihang Ju, Virginia P. Ronchi, (unknown), Hamid Boulares	1
19	The Poly(ADP-ribose) polymerases (PARPs): New roles in intracellular transport 2011 ·Cellular Signalling ·Zakaria Y. Abd Elmageed, Amarjit S. Naura, Youssef Errami, Mourad Zerfaoui	72
20	High-fat diet induces lung remodeling in ApoE-deficient mice: an association with an increase in circulatory and lung inflammatory factors 2009 ·Laboratory Investigation ·Amarjit S. Naura, Chetan P. Hans, Mourad Zerfaoui, Youssef Errami, Jihang Ju, Hogyoung Kim, Khalid Matrougui, (unknown), A. Hamid Boulares	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact